Tag Archives: auxl

Auxilium Mulls Endo Bid; Street Eyes A Higher Price

Specialty drugmaker Auxilium Pharmaceuticals (AUXL) adopted a poison-pill provision Wednesday to fend off a possible hostile bid from Endo International (ENDP), the morning after Endo announced an unsolicited $2.2 billion bid for Auxilium. Nonetheless, Auxilium said that it would review the offer, which comes to 28.10 a share, and the market certainly seemed to be rooting for it: Auxilium stock jumped 42% to a six-month high on the stock market

Auxilium Acquiring QLT For New Products, Low Taxes

U.S. specialty drugmaker Auxilium Pharmaceuticals (AUXL) said Thursday that it will acquire ophthalmology firm QLT (QLTI) in a stock swap and relocate to QLT’s home in Canada. Auxilium stock was up a fraction Thursday morning in heavy trading on the stock market, while QLT’s much cheaper stock jumped 18% to near 6.40. Auxilium shareholders will get 3.14 shares of QLT for each share of Auxilium owned, the companies said. They said that represented

Auxilium Q4 Beats Estimates, But Guidance Cautious

Auxilium Pharmaceuticals (AUXL) beat analysts’ Q4 expectations but guided in line Friday morning. Auxilium shares were up more than 2% in early trading in the stock market today, hitting its highest point since May 2010. Revenue totaled $125.9 million, about $14 million above analysts’ consensus. That was down 27% from the year-earlier quarter, but Q4 2012 included a one-time payment from Pfizer (PFE) on the termination of the two firms’